Market overview
The global hospital-at-home monitoring platforms market is worth USD 608 mn in 2026 and is forecast to reach USD 2.5 bn by 2036, growing at a 15.0% CAGR. United States is the largest country market and Platform software is the largest by component segment.
| Scope | Remote monitoring platforms with sensors, software and clinical alerting used to care for acutely ill patients at home as hospital-level admissions. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 520 mn |
| Value 2026 | USD 608 mn |
| Value 2036 | USD 2.5 bn |
| CAGR 2026-2036 | 15.0% |
| Volume 2026 | 468 thousand admissions |
| Volume 2036 | 1,893 thousand admissions |
| Average price 2026 | USD 1,300 per admission |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Hospital-at-Home Monitoring Platforms market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 608 mn |
| 2027 | USD 700 mn |
| 2028 | USD 805 mn |
| 2029 | USD 925 mn |
| 2030 | USD 1.1 bn |
| 2031 | USD 1.2 bn |
| 2032 | USD 1.4 bn |
| 2033 | USD 1.6 bn |
| 2034 | USD 1.9 bn |
| 2035 | USD 2.1 bn |
| 2036 | USD 2.5 bn |
Hospital-at-Home Monitoring Platforms market segmentation
By component
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Wearable and home devices | 36.0% | 29.8% | USD 219 mn | 12.8% |
| Platform software | 38.0% | 44.5% | USD 231 mn | 16.8% |
| Services and logistics | 26.0% | 25.7% | USD 158 mn | 14.8% |
By condition
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Heart failure and COPD | 38.0% | 37.8% | USD 231 mn | 14.9% |
| Infections and pneumonia | 24.0% | 23.8% | USD 146 mn | 14.9% |
| Post-surgical and oncology | 22.0% | 23.8% | USD 134 mn | 15.9% |
| Other acute conditions | 16.0% | 14.6% | USD 97 mn | 13.9% |
By monitoring mode
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Continuous | 36.0% | 44.0% | USD 219 mn | 17.3% |
| Intermittent | 40.0% | 36.0% | USD 243 mn | 13.8% |
| Hybrid on-demand | 24.0% | 20.0% | USD 146 mn | 12.9% |
By analytics level
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Threshold alerts | 40.0% | 28.0% | USD 243 mn | 11.0% |
| Trend-based prediction | 36.0% | 40.0% | USD 219 mn | 16.2% |
| Risk scoring with artificial intelligence | 24.0% | 32.0% | USD 146 mn | 18.4% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Health systems | 62.0% | 58.0% | USD 377 mn | 14.2% |
| Payers | 20.0% | 22.0% | USD 122 mn | 16.1% |
| Independent providers | 18.0% | 20.0% | USD 110 mn | 16.2% |
Top 25 countries for hospital-at-home monitoring platforms by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 98.5% of 2026 revenue and the 25 countries below together hold 99.6%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 438 mn | 72.0% | USD 1.8 bn | 15.0% |
| 2 | United Kingdom | USD 36 mn | 6.0% | USD 148 mn | 15.0% |
| 3 | Australia | USD 24 mn | 4.0% | USD 108 mn | 16.1% |
| 4 | Israel | USD 18 mn | 3.0% | USD 74 mn | 15.0% |
| 5 | Canada | USD 18 mn | 3.0% | USD 74 mn | 15.0% |
| 6 | Germany | USD 18 mn | 3.0% | USD 69 mn | 14.2% |
| 7 | Spain | USD 15 mn | 2.5% | USD 62 mn | 15.0% |
| 8 | France | USD 12 mn | 2.0% | USD 44 mn | 13.8% |
| 9 | Singapore | USD 9.1 mn | 1.5% | USD 39 mn | 15.7% |
| 10 | Japan | USD 9.1 mn | 1.5% | USD 32 mn | 13.4% |
| 11 | Italy | USD 0.67 mn | 0.1% | USD 2.5 mn | 13.9% |
| 12 | Netherlands | USD 0.55 mn | 0.09% | USD 2.0 mn | 13.7% |
| 13 | China | USD 0.55 mn | 0.09% | USD 3.0 mn | 18.4% |
| 14 | South Korea | USD 0.55 mn | 0.09% | USD 2.0 mn | 13.7% |
| 15 | Brazil | USD 0.49 mn | 0.08% | USD 2.2 mn | 16.4% |
| 16 | Switzerland | USD 0.49 mn | 0.08% | USD 1.7 mn | 13.5% |
| 17 | Sweden | USD 0.49 mn | 0.08% | USD 1.7 mn | 13.5% |
| 18 | India | USD 0.36 mn | 0.06% | USD 2.0 mn | 18.4% |
| 19 | Saudi Arabia | USD 0.36 mn | 0.06% | USD 1.7 mn | 16.8% |
| 20 | United Arab Emirates | USD 0.36 mn | 0.06% | USD 1.7 mn | 16.8% |
| 21 | Belgium | USD 0.36 mn | 0.06% | USD 1.5 mn | 15.0% |
| 22 | Denmark | USD 0.36 mn | 0.06% | USD 1.5 mn | 15.0% |
| 23 | Ireland | USD 0.36 mn | 0.06% | USD 1.5 mn | 15.0% |
| 24 | Norway | USD 0.30 mn | 0.05% | USD 0.98 mn | 12.5% |
| 25 | Mexico | USD 0.30 mn | 0.05% | USD 1.2 mn | 15.0% |
| Rest of world | USD 2.6 mn | 0.4% | USD 9.8 mn | 14.4% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Philips
- Masimo
- Medtronic
- GE HealthCare
- Baxter
- Omron Healthcare
Group 2: Regional and specialist players
- Biofourmis
- Vivalink
- BioIntelliSense
- DispatchHealth
- Current Health
- Doccla
- Biobeat
- Health Recovery Solutions
- Withings
Group 3: Emerging and niche players
- Inbound Health
- Cadence
- Vitls
- Sibel Health
- Spry Health
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the hospital-at-home monitoring platforms market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 15.0% is calculated from the resulting values.
The market is divided by component, by condition, by monitoring mode, by analytics level, by end user. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the hospital-at-home monitoring platforms market?
The global hospital-at-home monitoring platforms market is estimated at USD 520 mn in 2025 and USD 608 mn in 2026.
How fast will the hospital-at-home monitoring platforms market grow?
It is forecast to reach USD 2.5 bn by 2036, a compound annual growth rate of 15.0% from 2026, an increase of USD 1.9 bn.
Which country is the largest market for hospital-at-home monitoring platforms?
United States is the largest market by revenue at USD 438 mn in 2026, 72.0% of the global total. The three largest countries together hold 82.0%.
Which country is growing fastest?
Among the ten largest markets, Australia is growing fastest at 16.1% a year from 2026 to 2036.
Which hospital-at-home monitoring platforms segment is largest?
In the by component split, Platform software is the largest segment with 38.0% of 2026 revenue.
Who are the leading hospital-at-home monitoring platforms companies?
Global leaders include Philips, Masimo, Medtronic, GE HealthCare.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- High-end CellomicsUSD 610 mn · 7.0% CAGR
- Hospital-at-Home Vital Signs Monitoring PlatformsUSD 614 mn · 15.0% CAGR
- Transplant Biomarker Risk StratificationUSD 616 mn · 8.5% CAGR
- Neuromodulation Closed-Loop Brain-Computer InterfacesUSD 598 mn · 14.0% CAGR
- Clinic-Based Rehab Therapy RobotsUSD 632 mn · 9.5% CAGR
- Dystrophic Epidermolysis Bullosa ManagementUSD 632 mn · 8.0% CAGR
- Patient-Matched Orthopedic GuidesUSD 642 mn · 6.8% CAGR
- Capsule Endoscope and WorkstationsUSD 562 mn · 7.5% CAGR
← Hospital Supplies Hospital-at-Home Vital Signs Monitoring Platforms →